Kronos Bio Inc (NASDAQ:KRON) has a beta value of 1.76 and has seen 0.66 million shares traded in the recent trading session. The company, currently valued at $43.28M, closed the recent trade at $0.71 per share which meant it lost -$0.01 on the day or -1.62% during that session. The KRON stock price is -125.35% off its 52-week high price of $1.60 and 5.63% above the 52-week low of $0.67.
The consensus among analysts is that Kronos Bio Inc (KRON) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 4 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Kronos Bio Inc (NASDAQ:KRON) trade information
Sporting -1.62% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the KRON stock price touched $0.71 or saw a rise of 6.58%. Year-to-date, Kronos Bio Inc shares have moved -25.27%, while the 5-day performance has seen it change -2.87%. Over the past 30 days, the shares of Kronos Bio Inc (NASDAQ:KRON) have changed -8.72%.
Wall Street analysts have a consensus price target for the stock at $1, which means that the shares’ value could jump 29.0% from the levels at last check today.. The projected low price target is $1.0 while the price target rests at a high of $1.0. In that case, then, we find that the latest price level in today’s session is -40.85% off the targeted high while a plunge would see the stock gain -40.85% from the levels at last check today..
Kronos Bio Inc (KRON) estimates and forecasts
The company’s shares have lost -25.97% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -36.37% over the past 5 years.
KRON Dividends
Kronos Bio Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Kronos Bio Inc (NASDAQ:KRON)’s Major holders
The top two institutional holders are VIDA VENTURES ADVISORS, LLC with over 2.77 million shares worth more than $3.43 million. As of 2024-06-30, VIDA VENTURES ADVISORS, LLC held 4.6012% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.92 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.38 million and represent 3.1994% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 2.16% shares in the company for having 1.32 shares of worth $0.94 million while later fund manager owns 559.54 shares of worth $0.4 million as of Dec 31, 2024 , which makes it owner of about 0.92% of company’s outstanding stock.
